Food Allergy News and Research

Allergists and pediatricians have recommended since 2017 that parents start to introduce peanut product around the time their child begins solid foods to prevent peanut allergy. A new study being presented at this year’s American College of Allergy, Asthma and Immunology (ACAAI) Annual Scientific Meeting reveals that early egg introduction is associated with decreased egg allergy.

In 2017, the National Institute of Allergy and Infectious Diseases (NIAID) released guidelines to help parents introduce peanut products to their infants to prevent peanut allergy. A new study being presented at this year’s American College of Allergy, Asthma and Immunology (ACAAI) Annual Scientific Meeting reveals that although 58% of those surveyed reported their primary care physician (PCP) discussed early peanut introduction, only 40% of the parents said they received a recommendation.

It is safe for ALL people (6 months and older) with an egg allergy to get a flu vaccine every year. This is true no matter how severe your egg allergy was in the past. This includes people who have had anaphylaxis (a severe allergic reaction) to egg. Five organizations recommend that people get the flu vaccine every year, even if they have an egg allergy. These organizations are: Asthma and Allergy Foundation of America (AAFA) Centers for Disease Control and Prevention (CDC) American Academy...

If a child is allergic to tree nuts, are they able to touch acorns? Should they avoid them to be safe? Can they cause allergic reactions?

Update for Oct. 1, 2021: Did you miss the live stream of the PFDD meeting on food allergy? You can watch the recording . You can still share your experiences living with and managing food allergy. Send in your comments by Oct. 9, 2021. We will include your comments in the upcoming food allergy “Voice of the Patient Report.” We will send this report to FDA representatives. By sharing your story, you can help influence the future of treatments for food allergies. SUBMIT YOUR COMMENTS The...

COUR Pharmaceuticals, a biotechnology company developing novel immune-modifying nanoparticles to treat immune disorders (CNPs), today announced the U.S. Food and Drug Administration (FDA) has accepted the company's Investigational New Drug (IND) application for evaluation of COUR's CNP-201 in a proof-of-concept (Phase 1 / 2) study in people who are allergic to peanuts.

As regulators, the FDA recognizes they have an important task ahead of them that will require them to act expeditiously while undertaking an extremely meticulous and thoughtful review once we receive requests to authorize a COVID-19 vaccine for emergency use or submissions for approval of a COVID-19 vaccine for this population.

Aimmune Therapeutics, Inc., a Nestlé Health Science company developing and commercializing pharmaceutical therapies to prevent, manage, and treat food and metabolic-related diseases, today announced the publication of a longitudinal analysis that explored the safety, efficacy and food allergy-related quality of life of long-term treatment with PALFORZIA® [Peanut (Arachis hypogaea) Allergen Powder-dnfp, previously known as investigational agent AR101] in patients with peanut allergy.

Even if a child with a food allergy has had it all their life, each growth stage comes with its own concerns and challenges. In the “Spotlight: Transition to Adulthood,” we found that the period when a child moves into adulthood comes with a greater risk when food allergies are involved. It also causes a lot of anxiety for their parents.

Update: If you missed the webinar, we added the video below. We also included some resources on additional information discussed in the webinar, as well as answers to several questions we received. Kids With Food Allergies (KFA) hosted a webinar on May 13, 2021, on the latest research on food allergy anaphylaxis in infants and toddlers. The webinar was presented by: Michael Pistiner, MD, MMSc, pediatric allergist at MassGeneral Hospital for Children in Boston, Massachusetts Melanie Carver,...

The U.S. Food and Drug Administration today approved a nasal antihistamine for nonprescription use through a process called a partial prescription to nonprescription switch. The FDA approved Astepro (azelastine hydrochloride nasal spray, 0.15%) for seasonal and perennial allergic rhinitis—commonly known as allergies—for adults and children six years of age and older.

The Brood X cicadas are here. These are a type of insect that live underground and then emerge from the soil in every 17 years to mate. And there’s a lot of them. If you live anywhere from New York to Tennessee, you’ve probably seen them. Or you’re about to. To most kids (and a lot of adults), this sounds like something out of an action or science fiction movie. As much of the eastern half of the nation experiences this “swarmageddon,” the red-eyed critters are often hard for kids to resist...